Healthcare DIVE January 23, 2026
While the medications may be pricey, a multi-year study by Aon found consistent use correlates with lower medical cost growth and fewer hospitalizations for cardiovascular events.
Companies on the fence about offering an employee benefits plan that covers GLP-1s may find the following data helpful: A report from risk consultation firm Aon, released Jan. 13, suggests workers’ sustained GLP-1 use can reduce employers’ costs over time.
Analysts looked at data for more than 50 million people, including 192,000 GLP-1 users, for a little over two years. By the 30-month mark, the medical cost growth was 6% lower for people with diabetes using GLP-1s compared to people with diabetes who didn’t use GLP-1s, researchers found.
Another key factor was consistency:...
Today's Sponsors
Today's Sponsor